Global dialogue on non-amyloid targets for disease modification co-chairs announced

A global dialogue as part of the dementia landscape project series will gather international leaders on 21 October 2021 to explore future approaches to the development of disease modifying treatments in non-amyloid targets.

We are pleased to announce this dialogue will be led by Dr Maria Carrillo, chief science officer, Alzheimer's Association, and Professor Philip Scheltens, professor of cognitive neurology and director, Alzheimer Center, Amsterdam University Medical Centers.

The global project is reviewing international progress towards the 2025 dementia goals. At the G8 dementia summit in 2013, governments pledged to work together to advance research, improve care, raise awareness and prevent dementia. We are currently holding a series of global dialogue events of global experts to inform this project, and in 2021 the Council will publish a report on progress towards the 2025 goals.

Other dialogues that have been held as part of this series have included the topics of research, which have explored biomarkers and advances in treatments as well as in clinical trialscare, which assessed the models of care and the burden of caregivers, as well as on prevention, which looked at the state of play around current thinking in risk reduction strategies and lessons from other public health initiatives. We have also held other further dialogue events on technology in dementiadementia in low- and middle-income countries, data sharing for dementia research, ageing societies, and health system readiness.